Alzheimer’s vaccine triggers brain inflammation when brain amyloid burden is high
Tuesday, November 15th, 2011Patients with Alzheimer’s disease who are in the early stages of their illness will likely benefit most from vaccine therapies. This study is the first to show that mice with a large brain burden of amyloid protein — representative of many patients now receiving immunization — were much more likely ... continue reading